HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
Our team at the Congenital Hyperinsulinism Center at CHOP is working on a research study to determine whether an experimental gene therapy product, DTX401, is safe and effective in people with glycogen storage disease type Ia (GSDIa)
Understanding, developing, and applying gene and related cell and nucleic acid therapies to find cures for debilitating disorders.